Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) — Capital Reinvestment Ratio
Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Capital Reinvestment Ratio of 0.52x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥1.25 Billion) in capital expenditures (CN¥652.49 Million). Check Starlake Bioscience Co Inc Zhaoqing Guan tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Starlake Bioscience Co Inc Zhaoqing Guangdong Capital Reinvestment Ratio (1998–2025)
This chart tracks Starlake Bioscience Co Inc Zhaoqing Guangdong's Capital Reinvestment Ratio across 25 annual periods. For the full cash flow conversion analysis, see 600866 cash generation efficiency.
Annual Capital Reinvestment Ratio for Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)
Year-by-year Capital Reinvestment Ratio for Starlake Bioscience Co Inc Zhaoqing Guangdong from 1998 to 2025. See Starlake Bioscience Co Inc Zhaoqing Guan free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.58x | CN¥1.29 Billion | CN¥2.04 Billion | ▲ +492.5% |
| 2024 | 0.27x | CN¥2.40 Billion | CN¥638.50 Million | ▲ +43.6% |
| 2023 | 0.19x | CN¥2.03 Billion | CN¥375.83 Million | ▼ -31.8% |
| 2022 | 0.27x | CN¥1.66 Billion | CN¥452.34 Million | ▼ -74.4% |
| 2021 | 1.06x | CN¥192.63 Million | CN¥205.08 Million | ▼ -8.2% |
| 2020 | 1.16x | CN¥249.99 Million | CN¥289.89 Million | ▲ +57.0% |
| 2019 | 0.74x | CN¥213.17 Million | CN¥157.41 Million | ▲ +11.0% |
| 2018 | 0.67x | CN¥50.69 Million | CN¥33.71 Million | ▼ -34.4% |
| 2017 | 1.01x | CN¥40.05 Million | CN¥40.61 Million | ▲ +3.7% |
| 2016 | 0.98x | CN¥41.17 Million | CN¥40.26 Million | ▼ -97.4% |
| 2015 | 37.70x | CN¥2.75 Million | CN¥103.49 Million | ▲ +189.0% |
| 2011 | 13.05x | CN¥65.88 Million | CN¥859.52 Million | ▲ +244.3% |
| 2010 | 3.79x | CN¥104.63 Million | CN¥396.40 Million | ▲ +1816.9% |
| 2009 | 0.20x | CN¥316.73 Million | CN¥62.60 Million | ▼ -41.1% |
| 2008 | 0.34x | CN¥148.93 Million | CN¥49.97 Million | ▼ -63.1% |
| 2007 | 0.91x | CN¥82.28 Million | CN¥74.90 Million | ▼ -58.6% |
| 2006 | 2.20x | CN¥35.14 Million | CN¥77.37 Million | ▲ +47.8% |
| 2005 | 1.49x | CN¥46.83 Million | CN¥69.77 Million | ▼ -80.4% |
| 2004 | 7.60x | CN¥29.05 Million | CN¥220.76 Million | ▲ +932.9% |
| 2003 | 0.74x | CN¥149.70 Million | CN¥110.12 Million | ▲ +52.8% |
| 2002 | 0.48x | CN¥183.18 Million | CN¥88.18 Million | ▼ -62.1% |
| 2001 | 1.27x | CN¥60.82 Million | CN¥77.35 Million | ▲ +76.9% |
| 2000 | 0.72x | CN¥93.41 Million | CN¥67.16 Million | ▼ -52.1% |
| 1999 | 1.50x | CN¥52.97 Million | CN¥79.45 Million | ▼ -6.2% |
| 1998 | 1.60x | CN¥71.14 Million | CN¥113.73 Million | — |